Yıldız, Oğuzhan, Melek Karakurt Eryılmaz, Talat Aykut, Ömer Genç, Bahattin Engin Kaya, and Ali Fuat Gürbüz. 2026. “Reduced Efficacy of Nivolumab Following Prior Immunotherapy in Metastatic Renal Cell Carcinoma: Implications for Sequential Immune Checkpoint Inhibition”. EXPERIMENTAL BIOMEDICAL RESEARCH 9 (1):1-9. https://doi.org/10.30714/j-ebr.2026.262.